Invention Grant
![Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid](/docs/US/2020-03-24/US10597384B2/abs.jpg.600x600.jpg)
- Patent Title: Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
-
Application No.: US15807663Application Date: 2017-11-09
-
Publication No.: US10597384B2Publication Date: 2020-03-24
- Inventor: Ali Keshavarz-Shokri , Beili Zhang , Mariusz Krawiec
- Applicant: Vertex Pharmaceuticals Incorporated
- Applicant Address: US MA Boston
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Boston
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Main IPC: C07D405/12
- IPC: C07D405/12 ; A61K31/4709
![Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid](/abs-image/US/2020/03/24/US10597384B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methypyridin-2-yl)benzoic acid (Form I), pharmaceutical compositions thereof, and methods of treatment therewith.
Public/Granted literature
Information query
